{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T06:20:54Z","timestamp":1776579654282,"version":"3.51.2"},"reference-count":54,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T00:00:00Z","timestamp":1436832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Cryptococcus has emerged as a significant pathogen in immunocompromised patients. While the diagnostic testing and the antifungal treatment of cryptococcal infections have become firmly established in clinical practice, new developments and areas of ambiguity merit further consideration. These include the potential for donor transmission of Cryptococcus; cirrhosis-associated cryptococcosis, particularly during transplant candidacy; the utility of serum cryptococcal antigen testing of asymptomatic individuals in high-prevalence, poor-resource areas; pathogenesis and treatment of the immune reconstitution syndrome, specifically in relation to antiretroviral therapy and immunosuppressive medications; and new challenges posed by the emerging species of Cryptococcus gatti. In this article, we summarize the literature pertaining to these topics, focusing on recent progress.<\/jats:p>","DOI":"10.3390\/jof1020115","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T10:53:35Z","timestamp":1436871215000},"page":"115-129","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cryptococcus: Shedding New Light on an Inveterate Yeast"],"prefix":"10.3390","volume":"1","author":[{"given":"Ghady","family":"Haidar","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15240, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Singh","sequence":"additional","affiliation":[{"name":"VA Pittsburgh Healthcare System, Infectious Diseases Section, and University of Pittsburgh, Pittsburgh, PA 15240, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2015,7,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"a019760","DOI":"10.1101\/cshperspect.a019760","article-title":"Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis","volume":"4","author":"Fraser","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","article-title":"Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis","volume":"370","author":"Boulware","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/TP.0b013e318236cd1a","article-title":"How I treat cryptococcosis in organ transplant recipients","volume":"93","author":"Singh","year":"2012","journal-title":"Transplantation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/ajt.12116","article-title":"Cryptococcosis in solid organ transplantation","volume":"13","author":"Baddley","year":"2013","journal-title":"Am. J. Transplant."},{"key":"ref_5","first-page":"3287","article-title":"Cryptococcus neofomans","volume":"Volume 2","author":"Mandell","year":"2010","journal-title":"Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/322597","article-title":"Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy","volume":"33","author":"Pappas","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1086\/598936","article-title":"Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: Evidence-based evolving trends","volume":"48","author":"Sun","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3201\/eid0401.980109","article-title":"What makes cryptococcus neoformans a pathogen?","volume":"4","author":"Buchanan","year":"1998","journal-title":"Emerg. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Singh, N., Sifri, C.D., Silveira, F.P., Miller, R., Gregg, K.S., Huprikar, S., Lease, E.D., Zimmer, A., Dummer, J.S., and Spak, C.W. (2015). Cryptococcosis in patients with cirrhosis of the liver and posttransplant outcomes. Transplantation, in press.","DOI":"10.1097\/TP.0000000000000690"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/qjmed\/95.8.511","article-title":"Cryptococcaemia: Clinical features and prognostic factors","volume":"95","author":"Jean","year":"2002","journal-title":"QJM"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.1840080332","article-title":"Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis","volume":"8","author":"Runyon","year":"1988","journal-title":"Hepatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0168-8278(88)80465-3","article-title":"Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis","volume":"6","author":"Such","year":"1988","journal-title":"J. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Casadevall, A., and Perfect, J.R. (1998). Cryptococcus Neoformans, American Society for Microbiology Press.","DOI":"10.1128\/9781555818241"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/01.md.0000126760.45299.69","article-title":"Cryptococcus neoformans infection in patients with cirrhosis, including liver transplant candidates","volume":"83","author":"Singh","year":"2004","journal-title":"Medicine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1086\/656584","article-title":"Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients","volume":"51","author":"Sun","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1093\/cid\/ciq216","article-title":"Transmission of cryptococcus neoformans by organ transplantation","volume":"52","author":"Baddley","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3201\/eid0703.017302","article-title":"Cryptococcus neoformans infection in organ transplant recipients: Variables influencing clinical characteristics and outcome","volume":"7","author":"Husain","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM197804132981506","article-title":"Cryptococcal endophthalmitis after corneal transplantation","volume":"15","author":"Beyt","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00005792-199605000-00004","article-title":"Fungal infections in lung and heart-lung transplant recipients: Report of 9 cases and review of the literature","volume":"75","author":"Kanj","year":"1996","journal-title":"Medicine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/01.ico.0000157404.34774.1a","article-title":"Cryptococcus albidus keratitis after corneal transplantation","volume":"24","author":"Sarraf","year":"2005","journal-title":"Cornea"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00007890-197104000-00018","article-title":"Survival of a patient transplanted with a kidney infected with Cryptococcus neoformans","volume":"11","author":"Ooi","year":"1971","journal-title":"Transplantation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(07)70085-3","article-title":"Immune reconstitution syndrome associated with opportunistic mycoses","volume":"7","author":"Singh","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/cid\/ciu711","article-title":"Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: Implications for the management of immunosuppression","volume":"60","author":"Sun","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e1000384","DOI":"10.1371\/journal.pmed.1000384","article-title":"Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: A prospective cohort study","volume":"7","author":"Boulware","year":"2010","journal-title":"PLoS Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Parham, P. (2015). The Immune System, Garland Science. [4th ed.].","DOI":"10.1201\/9781317511571"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/cid\/cir276","article-title":"Opportunistic infection-associated immune reconstitution syndrome in transplant recipients","volume":"53","author":"Sun","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1086\/424746","article-title":"Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV seronegative woman","volume":"39","author":"Einsiedel","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/655785","article-title":"Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome","volume":"202","author":"Boulware","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e5575","DOI":"10.1371\/journal.pone.0005575","article-title":"Early antiretroviral therapy reduces aids progression\/death in individuals with acute opportunistic infections: A multicenter randomized strategy trial","volume":"4","author":"Zolopa","year":"2009","journal-title":"PLoS ONE"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1086\/652652","article-title":"Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa","volume":"50","author":"Makadzange","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/cid\/cit019","article-title":"Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis","volume":"56","author":"Bisson","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Scriven, J.E., Rhein, J., Hullsiek, K.H., von Hohenberg, M., Linder, G., Rolfes, M.A., Williams, D.A., Taseera, K., Meya, D.B., and Meintjes, G. (2015). Early art after cryptococcal meningitis is associated with cerebrospinal fluid pleocytosis and macrophage activation in a multisite randomized trial. J. Infect. Dis.","DOI":"10.1093\/infdis\/jiv067"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/511438","article-title":"Cryptococcus neoformans in organ transplant recipients: Impact of calcineurin-inhibitor agents on mortality","volume":"195","author":"Singh","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/AAC.00990-07","article-title":"Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: Correlation with outcome in solid organ transplant recipients with cryptococcosis","volume":"52","author":"Kontoyiannis","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/522993","article-title":"A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment","volume":"45","author":"Arend","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_36","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count \u2264 100 cells\/microl who start HIV therapy in resource-limited settings","volume":"51","author":"Meya","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1473-3099(11)70245-6","article-title":"Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive ugandan adults: A double-blind, randomised, placebo-controlled trial","volume":"11","author":"Wakeham","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e69288","DOI":"10.1371\/journal.pone.0069288","article-title":"Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa","volume":"8","author":"Jarvis","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e51291","DOI":"10.1371\/journal.pone.0051291","article-title":"Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda","volume":"7","author":"Butler","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Chang, L.W., Phipps, W.T., Kennedy, G.E., and Rutherford, G.W. (2005). Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD004773.pub2"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Ssekitoleko, R., Kamya, M.R., and Reingold, A.L. (2013). Primary prophylaxis for cryptococcal meningitis and impact on mortality in HIV: A systematic review and meta-analysis. Future Virol., 8.","DOI":"10.2217\/fvl.13.71"},{"key":"ref_43","unstructured":"WHO (2011). World Health Organization."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ajt.12094","article-title":"Screening of donor and recipient in solid organ transplantation","volume":"13","author":"Fischer","year":"2013","journal-title":"Am. J. Transplant."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1128\/CMR.00126-13","article-title":"Cryptococcus gattii infections","volume":"27","author":"Chen","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1473-3099(14)70945-4","article-title":"Management of Cryptococcus gattii meningoencephalitis","volume":"15","author":"Womack","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"MBio"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.4049\/jimmunol.1202526","article-title":"Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis","volume":"190","author":"Rosen","year":"2013","journal-title":"J. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/cid\/cit342","article-title":"Cryptococcosis due to Cryptococcus gattii","volume":"57","author":"Rolston","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cit341","article-title":"Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii","volume":"57","author":"Chen","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Perfect, J.R. (2012). The triple threat of cryptococcosis: It\u2019s the body site, the strain, and\/or the host. MBio, 3.","DOI":"10.1128\/mBio.00165-12"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/cid\/ciu581","article-title":"Antifungal combination therapy for invasive aspergillosis","volume":"59","author":"Espigado","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/01.tp.0000173774.74388.49","article-title":"Antifungal management practices and evolution of infection in organ transplant recipients with C. neoformans infection","volume":"80","author":"Singh","year":"2005","journal-title":"Transplantation"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/1\/2\/115\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:49:10Z","timestamp":1760215750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/1\/2\/115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,14]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,9]]}},"alternative-id":["jof1020115"],"URL":"https:\/\/doi.org\/10.3390\/jof1020115","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,14]]}}}